Medline Inc
NASDAQ:MDLN
Relative Value
There is not enough data to reliably calculate the relative value of MDLN.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
MDLN Competitors Multiples
Medline Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
M
|
Medline Inc
NASDAQ:MDLN
|
56.3B USD | 0 | 0 | 0 | 0 | |
| JP |
|
Hoya Corp
TSE:7741
|
9.5T JPY | 10.4 | 38 | 27.5 | 33 | |
| CH |
|
Alcon AG
SIX:ALC
|
31.6B CHF | 3.9 | 41.4 | 15.8 | 30.8 | |
| DK |
|
Coloplast A/S
CSE:COLO B
|
103.9B DKK | 3.8 | 26.4 | 13.7 | 16.4 | |
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
12.5B USD | 3.1 | 30.5 | 13.2 | 18.1 | |
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
4.9B GBP | 2.7 | 37.6 | 14.8 | 25.4 | |
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
6.3B USD | 1.2 | -17.1 | 17.8 | 57.6 | |
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
40.7B CNY | 9 | 24.8 | 22.4 | 22.4 | |
| JP |
A
|
Asahi Intecc Co Ltd
TSE:7747
|
851.7B JPY | 6.6 | 48.1 | 22.7 | 30.9 | |
| US |
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
4.9B USD | 3.2 | 21 | 13.4 | 16.5 | |
| CH |
|
Ypsomed Holding AG
SIX:YPSN
|
3.7B CHF | 4.8 | 19.4 | 12.5 | 17 |